SHL Telemedicine Ltd. is a leading developer and provider of advanced personal telemedicine solutions, specializing in systems for remote health monitoring and medical call center services. The company focuses primarily on cardiovascular and related chronic diseases, offering devices and platforms that enable users to transmit vital data such as 12-lead ECGs, blood pressure, weight, oxygen saturation, and breath exhalation measurements to professional medical teams via telephonic, Internet, or cellular connections. Key products include the SmartHeartPro, a hospital-grade ECG device with cloud storage and 24/7 review services; CardioSen’C, a cellular-digital 12-lead ECG transmitter for real-time arrhythmia and infarction detection; Cardio’B, a portable ECG device for easy home or on-the-go use; and the Central Communication Module (CCM) for seamless data transmission from multiple monitoring devices. SHL Telemedicine serves individual subscribers, healthcare providers, and communities worldwide, emphasizing user-friendly, compact technology that supports early intervention, reduces hospitalizations, and improves quality of life through immediate professional care. Founded in 1987 and headquartered in Tel Aviv, Israel, it plays a vital role in the growing telemedicine sector by bridging personal health devices with expert monitoring centers.